Skip to main content

Table 4 Change of liver function before and after GSMs-TACE \((\overline{x}\pm s)\)  

From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study

 

Pre-TACE

7 days after TACE

P

ALT (U/L)

50.70 ± 16.15

59.33 ± 17.53

0.052

AST (U/L)

49.41 ± 14.27

57.79 ± 16.91

0.054

TBIL (μmol/L)

24.53 ± 10.13

30.63 ± 11.58

0.063

ALB (g/L)

36.04 ± 7.23

32.19 ± 4.06

0.051

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us